Guidance Capital, Inc Bristol Myers Squibb CO Transaction History
Guidance Capital, Inc
- $305 Billion
- Q2 2024
A detailed history of Guidance Capital, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Guidance Capital, Inc holds 8,205 shares of BMY stock, worth $399,583. This represents 0.13% of its overall portfolio holdings.
Number of Shares
8,205
Previous 9,939
17.45%
Holding current value
$399,583
Previous $482 Million
19.06%
% of portfolio
0.13%
Previous 0.18%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...